search
Back to results

Telehealth Interventions for Cardiac Surgery (TICS)

Primary Purpose

Cardiac Valve Disease, Coronary Artery Disease, Surgical Complication

Status
Recruiting
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Telehealth Monitoring
Sponsored by
Liverpool Heart and Chest Hospital NHS Foundation Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Cardiac Valve Disease focused on measuring Telehealth, Remote Monitoring, Waiting List, Quality of Life

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Adult patients over 18y referred and accepted for cardiac surgery Able to consent to participate Exclusion Criteria: Urgent or emergent surgery Surgery planned within 3 weeks of first cardiac surgery outpatient review

Sites / Locations

  • Liverpool Heart and Chest HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Telehealth monitoring

Standard of Care

Arm Description

Telehealth remote monitoring provided by a specialised service with a monitoring and patient education app featuring: Symptom, blood pressure, weight, heart rate and oxygen saturation monitoring with optional step counters Customised algorithms with patient feedback for prehabilitation (e.g. patient self-reporting of symptoms, activities and health-related activities with positive feedback loops and recommendations for self-directed management) Centralised weekly review and escalation to expedited surgery if deteriorations noted Post-operative monitoring with symptom, blood pressure, weight, heart rate, oxygen saturation and photographic wound review with optional step counters

Standard of care will be no remote monitoring for patients whilst on the waiting list or after discharge from hospital. Access to tertiary services for advice, information or to report deteriorations will be through conventional existing modes such as printed or online literature provided at the time of outpatient review, telephone access to administrative staff allowing clinical information to be conveyed to the usual care team, and local primary care and emergency services for acute deteriorations. Existing standard of care remote services (e.g. wound monitoring by digital photograph reviews) will continue.

Outcomes

Primary Outcome Measures

Change from baseline to admission in Healthcare related Quality of Life Change (EQ5D5L)
EQ5D5L will be measured by electronic questionnaire by the patient or a researcher on their behalf and indexed for representation on a scale from 0 (worst health, equivalent to being dead) - 1 (best health). The difference in measures between baseline (randomisation) and admission for surgery (up to 52 weeks) will be measured.
Healthcare resource use during waiting list (composite counts of admission to hospital, A&E attendance and primary care appointment utilisation)
Composite counts of admissions to hospital, Accident & Emergency hospital attendance, and primary care appointments for this health condition or complications of this health condition adjudicated by the research team. The counts will be accrued from baseline (randomisation) to admission for surgery (up to 52 weeks).

Secondary Outcome Measures

Unplanned admissions pre- and post-surgery
Rates of unplanned admissions to hospital both pre- and post- surgery
Diabetes control
Change from baseline to admission on HbA1c
Smoking cessation
Change from baseline to admission on HbA1c
Post-operative Quality of Life Measures
Healthcare related Quality of Life Change (EQ5D5L change) as an indexed measure from 0 (worst health, equivalent to being dead) to 1 (best health).
Change in post-operative complications
Rates of post-operative complications including mortality, stroke, lower respiratory tract infections, surgical site infections
Length of hospital stay
Total in-hospital stay
Ventilator Time
Total cumulative time with invasive ventilation following index procedure
Length of intensive care stay
Total critical care stay for index admission
Weight loss
Change in body mass index on waiting list

Full Information

First Posted
October 25, 2022
Last Updated
October 3, 2023
Sponsor
Liverpool Heart and Chest Hospital NHS Foundation Trust
Collaborators
Liverpool Centre for Cardiovascular Science
search

1. Study Identification

Unique Protocol Identification Number
NCT05621954
Brief Title
Telehealth Interventions for Cardiac Surgery
Acronym
TICS
Official Title
Telehealth for Pre- and Post-Operative Monitoring of Cardiac Surgery Patients - A Randomised Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Recruiting
Study Start Date
April 4, 2023 (Actual)
Primary Completion Date
August 2024 (Anticipated)
Study Completion Date
December 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Liverpool Heart and Chest Hospital NHS Foundation Trust
Collaborators
Liverpool Centre for Cardiovascular Science

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The goal of this clinical trial is to compare telehealth monitoring at home against usual care in patients undergoing planned heart surgery. The main questions it aims to answer are: Can telehealth improve quality of life prior to surgery Can telehealth prevent serious deterioration requiring hospital or primary care attendance Participants awaiting heart surgery will be randomly allocated to either telehealth remote monitoring of symptoms, blood pressure, heart rate, oxygen levels and activity levels or they will be allocated to usual care which is unmonitored on the waiting list for surgery. Researchers will compare telehealth to usual care to see if it improves quality of life or prevents deteriorations on the waiting list.
Detailed Description
Patients on elective cardiac surgery waiting lists can deteriorate, presenting via acute services as urgent inpatients as a result of their decompensation and facing increased surgical risk. With increases in waiting times prevalent through the country, and healthcare resources under pressure from Covid-related backlogs, it is imperative to find ways to monitor and escalate the most vulnerable patients and to provide safe methods of providing healthcare interventions outside conventional hospital settings. Remote monitoring identifies patients at need, and allows tertiary-care led interventions to prevent deterioration in the first instance. Such facilities could also enhance recovery following treatment and reduce the risks of complications and readmissions post-operatively. The benefits and risks of such programmes is, however, not well understood: additional monitoring may increase the burden of responsibility on patients or monitoring facilities without providing additional safeguards to the patient. The advantages of early detection may not translate into improved outcomes and the onus on the patient to report in may reduce quality of life rather than enhance it. The researchers therefore seek to identify if telehealth monitoring can improve health related quality of life, reduce unplanned admissions and healthcare resource utilisation and enhance pre-habilitation using protocolised patient engagement facilities to reduce complications and improve risk-stratification metrics such as smoking status, diabetic control and BMI.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiac Valve Disease, Coronary Artery Disease, Surgical Complication
Keywords
Telehealth, Remote Monitoring, Waiting List, Quality of Life

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Pragmatic, single-centre, individual patient, randomized controlled trial
Masking
None (Open Label)
Masking Description
No masking
Allocation
Randomized
Enrollment
448 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Telehealth monitoring
Arm Type
Experimental
Arm Description
Telehealth remote monitoring provided by a specialised service with a monitoring and patient education app featuring: Symptom, blood pressure, weight, heart rate and oxygen saturation monitoring with optional step counters Customised algorithms with patient feedback for prehabilitation (e.g. patient self-reporting of symptoms, activities and health-related activities with positive feedback loops and recommendations for self-directed management) Centralised weekly review and escalation to expedited surgery if deteriorations noted Post-operative monitoring with symptom, blood pressure, weight, heart rate, oxygen saturation and photographic wound review with optional step counters
Arm Title
Standard of Care
Arm Type
No Intervention
Arm Description
Standard of care will be no remote monitoring for patients whilst on the waiting list or after discharge from hospital. Access to tertiary services for advice, information or to report deteriorations will be through conventional existing modes such as printed or online literature provided at the time of outpatient review, telephone access to administrative staff allowing clinical information to be conveyed to the usual care team, and local primary care and emergency services for acute deteriorations. Existing standard of care remote services (e.g. wound monitoring by digital photograph reviews) will continue.
Intervention Type
Procedure
Intervention Name(s)
Telehealth Monitoring
Other Intervention Name(s)
Docobo, Remote Monitoring, Doc@Home
Intervention Description
Connected devices and smartphone apps to measure symptoms and observations at home, with centralisation of results to a staffed hub
Primary Outcome Measure Information:
Title
Change from baseline to admission in Healthcare related Quality of Life Change (EQ5D5L)
Description
EQ5D5L will be measured by electronic questionnaire by the patient or a researcher on their behalf and indexed for representation on a scale from 0 (worst health, equivalent to being dead) - 1 (best health). The difference in measures between baseline (randomisation) and admission for surgery (up to 52 weeks) will be measured.
Time Frame
From baseline to admission for surgery (up to 52 weeks)
Title
Healthcare resource use during waiting list (composite counts of admission to hospital, A&E attendance and primary care appointment utilisation)
Description
Composite counts of admissions to hospital, Accident & Emergency hospital attendance, and primary care appointments for this health condition or complications of this health condition adjudicated by the research team. The counts will be accrued from baseline (randomisation) to admission for surgery (up to 52 weeks).
Time Frame
From baseline (randomisation) to admission for surgery (up to 52 weeks)
Secondary Outcome Measure Information:
Title
Unplanned admissions pre- and post-surgery
Description
Rates of unplanned admissions to hospital both pre- and post- surgery
Time Frame
From baseline to discharge from outpatient cardiac surgery service (up to 52 weeks)
Title
Diabetes control
Description
Change from baseline to admission on HbA1c
Time Frame
From baseline (randomisation) to admission for surgery (up to 52 weeks)
Title
Smoking cessation
Description
Change from baseline to admission on HbA1c
Time Frame
From baseline (randomisation) to admission for surgery (up to 52 weeks)
Title
Post-operative Quality of Life Measures
Description
Healthcare related Quality of Life Change (EQ5D5L change) as an indexed measure from 0 (worst health, equivalent to being dead) to 1 (best health).
Time Frame
From discharge from hospital admission to discharge from outpatient cardiac surgery service (up to 52 weeks)
Title
Change in post-operative complications
Description
Rates of post-operative complications including mortality, stroke, lower respiratory tract infections, surgical site infections
Time Frame
From discharge from hospital admission to discharge from outpatient cardiac surgery service (up to 52 weeks)
Title
Length of hospital stay
Description
Total in-hospital stay
Time Frame
From admission for surgery to discharge from hospital (up to 52 weeks)
Title
Ventilator Time
Description
Total cumulative time with invasive ventilation following index procedure
Time Frame
From admission for surgery to discharge from hospital (up to 52 weeks)
Title
Length of intensive care stay
Description
Total critical care stay for index admission
Time Frame
From admission for surgery to discharge from hospital (up to 52 weeks)
Title
Weight loss
Description
Change in body mass index on waiting list
Time Frame
From baseline (randomisation) to admission for surgery (up to 52 weeks)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult patients over 18y referred and accepted for cardiac surgery Able to consent to participate Exclusion Criteria: Urgent or emergent surgery Surgery planned within 3 weeks of first cardiac surgery outpatient review
Facility Information:
Facility Name
Liverpool Heart and Chest Hospital
City
Liverpool
State/Province
Mersey
ZIP/Postal Code
L14 3PE
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jennifer Crooks
Phone
01516001467
Email
jennifer.crooks@lhch.nhs.uk
First Name & Middle Initial & Last Name & Degree
Nicola Browning
Phone
01516001467
Email
nicola.browning@lhch.nhs.uk
First Name & Middle Initial & Last Name & Degree
Bilal Kirmani, FRCS
First Name & Middle Initial & Last Name & Degree
Maureen Morgan
First Name & Middle Initial & Last Name & Degree
Haytham Sabry, FRCS

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
There is no plan to make data widely available. However, should a legitimate request be made by bona fide researchers with data protection legislation equivalent to European Union or United Kingdom General Data Protection Regulations (GDPR), this would not be discounted out of hand. Governance procedures to fully anonymise all identifiable details would be required for any individual participant data, but protocols, analytic source code, data collection forms etc would be shared after publication of the study.

Learn more about this trial

Telehealth Interventions for Cardiac Surgery

We'll reach out to this number within 24 hrs